Photodynamic Therapy Devices Market Size, Share, By Product Type (Photosensitizer Drugs, Aminolevulinic Acid, Porphyrin Derivatives, Chlorine, and Others), By Application (Cancer, Actinic Keratosis, Acne, Psoriasis, and Others), and By Region – Trends, Analysis, and Forecast till 2034

Report Code: PMI553124 | Publish Date: July 2024 | No. of Pages: 178

Photodynamic Therapy Devices Market Companies

  • GALDERMA
  • Biofrontera AG
  •  Sun Pharmaceuticals Industries Ltd.
  •  LUMIBIRD Groups (Quantel Medical)
  •  Modulight Corporation
  •  Quest PharmaTech, Inc.
  •  Theralase Technologies Inc.
  •  SUS Advancing Tecchnology CO., Ltd.

Recent News:

  • Biofrontera announces the June 2024 release of the RhodoLED XL Lamp, a new red-light source that has received FDA clearance. This innovative gadget, with its cutting-edge engineering, sturdy, elegant design, and user-friendly interface, marks a significant advancement in PDT therapy innovation. During treatment, it should be simple to move around and adapt to various patient positions.
  • Topical Actinic Keratosis Treatment, February 2021, first released in the US According to a press statement from the firm, Almirall has announced the introduction of tirbanibulin, a novel microtubule inhibitor, for the topical treatment of actinic keratosis on the face or scalp in Klisyri by Almirall.